London · Delayed Price · Currency is GBP · Price in GBX Capital Earnings Call Transcripts
Fiscal Year 2025
-
Flat revenue and EBITDA year-on-year masked a strong H2 rebound, with MSALABS turning profitable and the investment portfolio delivering standout returns. 2026 guidance targets over 20% revenue growth, supported by robust demand and new long-term contracts.
-
Shareholders approved resolutions for a $40 million capital raise to fund growth amid rising demand in mining services. The company highlighted strong institutional support, robust earnings outlook, and strategic retention of high-performing equity investments.
-
Revenue declined 6% year-over-year, but operational turnaround in Q2 led to improved cash flow and reduced net debt. Raised revenue guidance reflects strong momentum in drilling, mining, and laboratory segments, with robust market conditions supporting a positive outlook.
-
The AGM covered improved financial performance, management changes, and strategic expansion, especially in North America. Shareholder resolutions were presented and voted on by poll, with final results to be published. Key risks included share price volatility and contract optimization.
Fiscal Year 2024
-
Record 2024 revenue was offset by lower profitability due to contract transitions and ramp-up delays. 2025 guidance anticipates a temporary dip before growth resumes, driven by new mining contracts and improved lab performance. Strong commodity prices and industry demand support a positive outlook.
-
Revenue grew nearly 10% year-over-year in H1 2024, with a strong 25% EBITDA margin and robust ROCE. Major investments in the U.S. and Gabon are ramping up, while proceeds from a $31M asset sale will reduce debt and support continued dividends.
-
The meeting covered strong financial growth, new contracts, and expansion across business pillars, with 2024 revenue guidance set at $355–$375 million. Shareholders voted on 15 resolutions, and Q&A addressed lab profitability and capital allocation strategies.